 |
|
The Korean Journal of Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma
Korean J Hepatol. 2009;15(2):227-230. Published online 2009 Jun 30 DOI: https://doi.org/10.3350/kjhep.2009.15.2.227
|
|
Citations to this article as recorded by
 Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Joong-Won Park, Richard S. Finn, Jun Suk Kim, Mark Karwal, Ruby K. Li, Fuad Ismail, Melanie Thomas, Rosemarie Harris, Christine Baudelet, Ian Walters, Jean-Luc Raoul
Clinical Cancer Research.2011; 17(7): 1973. CrossRef
|